Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

Freenome hits record high of $14.48

Freenome’s stock climbed to a record high of $14.48, bringing the company’s market capitalization to about $1.5 billion. Over the past year the share price rose 35.27% and currently trades above InvestingPro’s fair-value estimate. TD Cowen, BTIG and Jefferies initiated coverage with buy ratings and $17.00 price targets, highlighting Freenome’s potential in blood-based cancer screening tests and partnerships with Abbott and Roper. Investors should weigh the strong price momentum against signs of possible overvaluation. » Altro su de.investing.com

Metrica	Valore
Capitalizzazione di mercato	104,13 Mln €
Numero di azioni	8,16 Mln
Massimo/minimo a 52 settimane	13,02 € - 8,59 €
Dividendi	No
Beta	0,35
Rapporto P/E	-
Rapporto PEG	-
Rapporto P/B	-
Rapporto P/S	-